NASDAQ · Biotechnology

Kineta, Inc. (KA) Stock

$0.57 -30.77% NASDAQ: KA Healthcare

Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications.

Valuation

MetricValue
Price$0.57
Market Cap$7.05M
P/E Ratio-0.40
P/B Ratio-0.58
P/S Ratio0.00
EPS (TTM)$-1.42
52-Week High$5.39
52-Week Low$0.33
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE374.84%
ROA-1700.00%
ROCE114.03%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.05
Current Ratio0.08

Annual Financials (USD)

Metric20202021202220232024
Revenue$10.0M$9.0M$2.0M$5.0M$0
Operating Profit$-3.0M$-11.0M$-42.0M$-16.0M$-14.0M
Net Profit$-14.0M$-12.0M$-63.0M$-14.0M$-17.0M
EPS$-41.26$-8.14$-12.80$-1.28$-1.42
Op Margin-29.7%-122.0%-2126.5%-288.9%—

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$14.0M$13.0M$17.0M$10.0M$1.0M
Total Liabilities$36.0M$25.0M$13.0M$7.0M$13.0M
Cash$11.0M$11.0M$13.0M$6.0M$1.0M
Borrowings$25.0M$22.0M$2.0M$1.0M$1.0M

Latest News

Karman Space & Defense Secures $21.3 Million US Navy Contract from Northrop Grumman MT Newswires · Jul 22, 2026 Karman Space & Defense Awarded $21.3 Million Contract by Northrop Grumman for U.S. Navy MK 54 Torpedo Fleet Exercise Section Business Wire · Jul 22, 2026 Karyopharm Therapeutics (KPTI) Soars 5.3%: Is Further Upside Left in the Stock? Zacks · Jul 22, 2026 KRMN: Initiating coverage on KRMN Argus Research · Jul 22, 2026 Karman to Acquire Walker Precision Engineering for $94 Million MT Newswires · Jul 20, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$2.0M$-18.0M$-19.0M$-16.0M$-12.0M
Investing Cash Flow$0$0$9.0M$0$0
Financing Cash Flow$0$0$0$0$6.0M
Net Cash Flow$6.0M$0$2.0M$-7.0M$-5.0M
Free Cash Flow$2.0M$-18.0M$-19.0M$-16.0M$-12.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-0.52
FCF Yield-164.18%
Quick Ratio0.08
Interest Coverage-98.06
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIORBiora Therapeutics, Inc. $0.22 +0.00% 0.00 $994994 0.00%
CSCICOSCIENS Biopharma Inc. $2.72 +0.00% -0.35 $8.57M 0.00%
ENTOEntero Therapeutics, Inc. $2.85 -5.00% -0.82 $13.58M 0.00%
EPIXESSA Pharma Inc. $0.20 -1.85% -0.87 $9.52M 0.00%
FRTXFresh Tracks Therapeutics, Inc. $0.94 -0.53% -0.97 $5.59M 0.00%

About Kineta, Inc.

Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.

Kineta, Inc. is headquartered in US.

Kineta, Inc. (KA) stock trades at $0.57 with a market capitalization of $7.05M. The stock is valued at a price-to-earnings (P/E) ratio of -0.40, price-to-book of -0.58, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.33 and $5.39, and currently trades 89.4% below its 52-week high.

On profitability, Kineta, Inc. generates a return on equity (ROE) of 374.84% — well above the market average, a sign of a high-quality business, return on capital employed of 114.03%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: kinetabio.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides